Low Tze-Yi, Goh Brian K P
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore.
Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital; Duke-Nus Medical School, Singapore.
J Minim Access Surg. 2019 Jul-Sep;15(3):204-209. doi: 10.4103/jmas.JMAS_69_18.
Recently, there have been several reports on minimally-invasive surgery for extended pancreatectomy (MIEP) in the literature. However, to date, only a limited number of studies reporting on the outcomes of MIEP have been published. In the present study, we report our initial experience with MIEP defined according to the latest the International Study Group for Pancreatic Surgery (ISPGS) guidelines.
Over a 14-month period, a total of 6 consecutive MIEP performed by a single surgeon at a tertiary institution were identified from a prospectively maintained surgical database. EP was defined as per the 2014 ISPGS consensus. Hybrid pancreatoduodenectomy (PD) was defined as when the entire resection was completed through minimally-invasive surgery, and the reconstruction was performed open through a mini-laparotomy incision.
Six cases were performed including 2 robotic extended subtotal pancreatosplenectomies with gastric resection, 1 laparoscopic-assisted (hybrid) extended PD with superior mesenteric vein wedge resection, 2 robotic-assisted (hybrid) PD with portal vein resection (1 interposition Polytetrafluoroethylene graft reconstruction and 1 wedge resection) and 1 totally robotic PD with wedge resection of portal vein. Median estimated blood loss was 400 (250-1500) ml and median operative time was 713 (400-930) min. Median post-operative stay was 9 (6-36) days. There was 1 major morbidity (Grade 3b) in a patient who developed early post-operative intestinal obstruction secondary to port site herniation necessitating repeat laparoscopic surgery. There were no open conversions and no in-hospital mortalities.
Based on our initial experience, MIEP although technically challenging and associated with long operative times, is feasible and safe in highly selected cases.
最近,文献中有几篇关于扩大胰切除术的微创手术(MIEP)的报道。然而,迄今为止,仅有数量有限的关于MIEP结果的研究发表。在本研究中,我们报告了根据最新的国际胰腺手术研究组(ISPGS)指南定义的MIEP的初步经验。
在14个月的时间里,从一个前瞻性维护的手术数据库中识别出由一名外科医生在一家三级医疗机构连续进行的6例MIEP。根据2014年ISPGS共识定义扩大胰切除术(EP)。混合胰十二指肠切除术(PD)定义为整个切除通过微创手术完成,重建通过迷你剖腹切口开放进行手术。
共进行了6例手术,包括2例机器人辅助扩大次全胰脾切除术加胃切除术,1例腹腔镜辅助(混合)扩大PD加肠系膜上静脉楔形切除术,2例机器人辅助(混合)PD加门静脉切除术(1例置入聚四氟乙烯移植物重建和1例楔形切除术),以及1例全机器人PD加门静脉楔形切除术。估计中位失血量为400(250 - 1500)ml,中位手术时间为713(400 - 930)分钟。中位术后住院时间为9(6 - 36)天。1例患者发生主要并发症(3b级),该患者术后早期因切口疝导致肠梗阻,需要再次进行腹腔镜手术。没有中转开腹手术,也没有院内死亡病例。
基于我们的初步经验,MIEP虽然在技术上具有挑战性且手术时间长,但在经过严格筛选的病例中是可行且安全的。